Abdullah Pandor BSc Hons. (Oxford Brookes), MSc (Aberdeen)

HEDS, ScHARR
The University of Sheffield
Regent Court
30 Regent Street
Sheffield
S1 4DA
UK

Office:

Tel: (+44) (0)114 222 0778
Fax: (+44) (0)114 272 4095

E-mail: a.pandor@sheffield.ac.uk

Biography

I obtained my first degree in Nutrition & Food Science from Oxford Brookes University and my MSc in Human Nutrition and Metabolism from the University of Aberdeen. I also spent 6 months at Wageningen Agricultural University, The Netherlands, where I completed my MSc thesis.

I joined ScHARR in 1999. My work has included literature reviews on newborn screening for inborn errors of metabolism, statins for the prevention of cardiovascular events, early high-dose lipid-lowering therapy to avoid cardiac events, clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes, and oxaliplatin, capecitabine for the adjuvant treatment of colon cancer and single technology appraisals of febuxostat for the management of hyperuricaemia in patients with gout and mifamurtide for osteosarcoma.

I am a member of the Society for Social Medicine (SSM), Health Technology Assessment international (HTAi) and the ScHARR Technology Assessment Group (ScHARR-TAG).

Research Interests

My research interests are:

• Systematic review and meta-analysis of evidence for clinical effectiveness
• Application and development of methods for the systematic review and synthesis of diagnostic evaluations in the field of health services research
• Network meta-analysis (indirect and mixed treatment comparisons)

Teaching interests

My teaching interests are:

• Systematic reviews and critical appraisal techniques

Professional activities

I am a member of ScHARR-TAG (since October 2003), where I undertake health technology assessments (HTA) for the National Institute for Health and Clinical Excellence (NICE), NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC), the Department of Health and others. I also undertake undergraduate and post-graduate teaching within ScHARR.

Current projects

I am currently working on the following projects:

• Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation (on behalf of the NETSCC HTA)
• Home telemonitoring or structured telephone support programmes for patients with chronic heart failure: a systematic review and an economic evaluation (on behalf of the NETSCC HTA)
• Cladribine for multiple sclerosis – A Single Technology Appraisal (on behalf of NICE)

Key publications

• Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials. J Intern Med, 2009, 265;(5): 568-580 (with R. Ara, I. Tumur, A. Wilkinson, S. Paisley and others) [link]
  
• Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation. Health Technology Assessment 2009, 13; (34):1-74, 75-118 (with R Ara, J Stevens, A Rees and R Rafia)
• Ezetimibe for the treatment of hypercholesterolaemia - A systematic review and economic evaluation. Health Technology Assessment, 2008, 12:21 (with R. Ara, A. Duenas, S. Paisley, J. Chilcott and others) [link]
• A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technology Assessment, 2007, 11:14 (with S. Ward, M. Lloyd-Jones, M. Holmes, R. Ara, and others) [link]
• The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: Systematic review and economic evaluation. Health Technology Assessment, 2006, 10:41 (with S. Eggington, S. Paisley, P. Tappenden, and P. Sutcliffe) [link]
  
• Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Health Technology Assessment, 2004, 8:12 (with J. Eastham, C. Beverley, J. Chilcott and S. Paisley). [link]